267 related articles for article (PubMed ID: 1634229)
21. Impairment of ganglioside metabolism in cultured fibroblasts from Salla patients.
Pitto M; Chigorno V; Renlund M; Tettamanti G
Clin Chim Acta; 1996 Mar; 247(1-2):143-57. PubMed ID: 8920233
[TBL] [Abstract][Full Text] [Related]
22. Isolation, characterization, and proteolysis of human prosaposin, the precursor of saposins (sphingolipid activator proteins).
Hiraiwa M; O'Brien JS; Kishimoto Y; Galdzicka M; Fluharty AL; Ginns EI; Martin BM
Arch Biochem Biophys; 1993 Jul; 304(1):110-6. PubMed ID: 8323276
[TBL] [Abstract][Full Text] [Related]
23. Correction of sulfatide metabolism after transfer of prosaposin cDNA to cultured cells from a patient with SAP-1 deficiency.
Rafi MA; Amini S; Zhang XL; Wenger DA
Am J Hum Genet; 1992 Jun; 50(6):1252-8. PubMed ID: 1350885
[TBL] [Abstract][Full Text] [Related]
24. Patterns of complex carbohydrate storage in four lysosomal storage diseases: fucosidosis, GM1-gangliosidosis, GM2-gangliosidosis (Sandhoff variant) and mannosidosis.
Dawson G; Chen Tsay G
Biochem Exp Biol; 1977; 13(1):15-25. PubMed ID: 418790
[No Abstract] [Full Text] [Related]
25. Saposins (sap) A and C activate the degradation of galactosylsphingosine.
Harzer K; Hiraiwa M; Paton BC
FEBS Lett; 2001 Nov; 508(1):107-10. PubMed ID: 11707278
[TBL] [Abstract][Full Text] [Related]
26. Synopsis: gangliosidoses.
Schwab ME; Vassella F
Neuropediatrics; 1984 Sep; 15 Suppl():107-9. PubMed ID: 6100793
[TBL] [Abstract][Full Text] [Related]
27. Ganglioside GM1 metabolism in living human fibroblasts with beta-galactosidase deficiency.
Mancini GM; Hoogeveen AT; Galjaard H; Mansson JE; Svennerholm L
Hum Genet; 1986 May; 73(1):35-8. PubMed ID: 3086209
[TBL] [Abstract][Full Text] [Related]
28. Ganglioside GM2 is substrate for a sialidase in MDCK cells.
Marchesini S; Benaglia G; Piccinotti A; Bresciani R; Preti A
FEBS Lett; 1998 May; 428(1-2):115-7. PubMed ID: 9645488
[TBL] [Abstract][Full Text] [Related]
29. Sphingolipid activator protein D (sap-D) stimulates the lysosomal degradation of ceramide in vivo.
Klein A; Henseler M; Klein C; Suzuki K; Harzer K; Sandhoff K
Biochem Biophys Res Commun; 1994 May; 200(3):1440-8. PubMed ID: 8185598
[TBL] [Abstract][Full Text] [Related]
30. Assay of ganglioside GM2-N-acetyl-beta-D-galactosaminidase activity in human fibroblasts employing the natural activator protein--diagnosis of variant forms of GM2 gangliosidosis.
Erzberger A; Conzelmann E; Sandhoff K
Clin Chim Acta; 1980 Dec; 108(3):361-8. PubMed ID: 6781795
[TBL] [Abstract][Full Text] [Related]
31. Characterization of a mutation in a family with saposin B deficiency: a glycosylation site defect.
Kretz KA; Carson GS; Morimoto S; Kishimoto Y; Fluharty AL; O'Brien JS
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2541-4. PubMed ID: 2320574
[TBL] [Abstract][Full Text] [Related]
32. The effect of carbohydrate removal on stability and activity of saposin B.
Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
[TBL] [Abstract][Full Text] [Related]
33. Processing of sphingolipid activator proteins and the topology of lysosomal digestion.
Sandhoff K; Kolter T
Acta Biochim Pol; 1998; 45(2):373-84. PubMed ID: 9821868
[TBL] [Abstract][Full Text] [Related]
34. Prosaposin and prosaptide, a peptide from prosaposin, induce an increase in ganglioside content on NS20Y neuroblastoma cells.
Misasi R; Sorice M; Carson GS; Griggi T; Lenti L; Pontieri GM; O'Brien JS
Glycoconj J; 1996 Apr; 13(2):195-202. PubMed ID: 8737244
[TBL] [Abstract][Full Text] [Related]
35. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
[TBL] [Abstract][Full Text] [Related]
36. The biochemical basis of gangliosidoses.
Sandhoff K; Conzelmann E
Neuropediatrics; 1984 Sep; 15 Suppl():85-92. PubMed ID: 6242704
[No Abstract] [Full Text] [Related]
37. Ganglioside loading of cultured fibroblasts: a provocative method for the diagnosis of the GM2 gangliosidoses.
Charrow J; Binns HJ
Clin Chim Acta; 1986 Apr; 156(1):41-9. PubMed ID: 2938852
[TBL] [Abstract][Full Text] [Related]
38. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
[TBL] [Abstract][Full Text] [Related]
39. Intracellular degradation of sulforhodamine-GM1: use for a fluorescence-based characterization of GM2-gangliosidosis variants in fibroblasts and white blood cells.
Agmon V; Khosravi R; Marchesini S; Dinur T; Dagan A; Gatt S; Navon R
Clin Chim Acta; 1996 Mar; 247(1-2):105-20. PubMed ID: 8920231
[TBL] [Abstract][Full Text] [Related]
40. Evidence for sialidase hydrolyzing gangliosides GM2 and GM1 in rat liver plasma membrane.
Miyagi T; Tsuiki S
FEBS Lett; 1986 Oct; 206(2):223-8. PubMed ID: 3758350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
